Try our beta test site
232 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hepatitis C"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital
Condition: Hepatitis C
Intervention: Other: community based hepatitis C care and treatment
2 Recruiting Prevalence and Screening of Hepatitis C in Belgium in 2015
Condition: Hepatitis C
Interventions: Other: Questionnaire;   Procedure: HCV serology
3 Recruiting Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients
Condition: Hepatitis C
Intervention:
4 Not yet recruiting Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4
Condition: Hepatitis C
Interventions: Drug: Daclatasvir;   Drug: Sofosbuvir;   Drug: Ribavirin
5 Recruiting Study of Oral Treatments for Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: sofosbuvir/ledipasvir;   Drug: ombitasvir/paritaprevir/ritonavir (Phase 1 only);   Drug: elbasvir/grazoprevir;   Drug: Dasabuvir
6 Recruiting Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil
Condition: Hepatitis C Virus
Intervention:
7 Recruiting Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C Infection
Intervention:
8 Recruiting C Tracker, Hepatitis C, Care & Collaboration - Patient Reported Outcomes Survey Study
Condition: Hepatitis C
Intervention:
9 Recruiting HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Condition: Hepatitis C
Intervention:
10 Recruiting Surveillance and Treatment of Prisoners With Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Sofosbuvir/velpatasvir
11 Recruiting Hepatitis C Alcohol Reduction Treatment
Condition: Hepatitis C, Chronic; AUD
Interventions: Behavioral: Brief alcohol counseling;   Behavioral: Group and Individual Therapy Sessions
12 Recruiting Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World
Condition: Chronic Hepatitis C
Intervention: Drug: sofosbuvir/ledipasvir
13 Recruiting Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)
Condition: Hepatitis C
Interventions: Drug: sofosbuvir;   Drug: ledipasvir;   Drug: Ribavirin
14 Recruiting Immune Monitoring of Hepatitis C Under DAA Therapy
Condition: Hepatitis C
Intervention:
15 Recruiting Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Condition: Hepatitis C
Intervention:
16 Recruiting Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience
Condition: Hepatitis C
Intervention: Drug: Sofosbuvir and simeprevir
17 Not yet recruiting Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients
Condition: Hepatitis C
Interventions: Drug: Sofosbuvir/Ledipasvir 12W;   Drug: Sofosbuvir/Ledipasvir plus Ribavirin 12W;   Drug: Sofosbuvir/Ledipasvir 24W;   Drug: Sofosbuvir/Ledipasvir plus Ribavirin 24W
18 Recruiting Hepatitis C Infection in World Trade Center Responders
Condition: Hepatitis C Infection
Intervention:
19 Recruiting Treatment as Prevention for Hepatitis C in Iceland
Condition: Hepatitis C
Intervention:
20 Recruiting LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Condition: Hepatitis C
Interventions: Drug: Sofosbuvir/Ledipasvir x 8 weeks;   Drug: Sofosbuvir/Ledipasvir x 12 weeks;   Drug: Sofosbuvir/Ledipasvir + Ribavirin x 12 weeks

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.